Point72 (DIFC) Ltd

SEC CIK: 0002017863
Latest filing: Nov 14, 2025

SEC filings (opens in a new tab)

DNLI holding history

Denali Therapeutics Inc. in every 13F filed by Point72 (DIFC) Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNLI overview All 13F holders of DNLI Full Q3 2025 holdings

Shares (Q3 2025): 43
Value: $622
% of portfolio: <0.1%
Quarters held: 3; Since Q3 2024

Holdings of DNLI by Point72 (DIFC) Ltd, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2025	43	$622	<0.1%	+43	New	Holders
Q1 2025	0	$0	0.0%	−7,438−100.0%	Sold out	Holders
Q4 2024	7,438	$151.6K	<0.1%	+7,383+13,423.6%	Added	Holders
Q3 2024	55	$1.61K	<0.1%	+55	New	Holders